328 related articles for article (PubMed ID: 18647134)
1. Gender and renal function influence plasma levels of copeptin in healthy individuals.
Bhandari SS; Loke I; Davies JE; Squire IB; Struck J; Ng LL
Clin Sci (Lond); 2009 Feb; 116(3):257-63. PubMed ID: 18647134
[TBL] [Abstract][Full Text] [Related]
2. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
[TBL] [Abstract][Full Text] [Related]
3. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Voors AA; von Haehling S; Anker SD; Hillege HL; Struck J; Hartmann O; Bergmann A; Squire I; van Veldhuisen DJ; Dickstein K;
Eur Heart J; 2009 May; 30(10):1187-94. PubMed ID: 19346228
[TBL] [Abstract][Full Text] [Related]
4. C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction.
Kelly D; Squire IB; Khan SQ; Quinn P; Struck J; Morgenthaler NG; Davies JE; Ng LL
J Card Fail; 2008 Nov; 14(9):739-45. PubMed ID: 18995178
[TBL] [Abstract][Full Text] [Related]
5. Copeptin in heart transplant recipients depends on kidney function and intraventricular septal thickness.
Przybylowski P; Malyszko J; Malyszko JS
Transplant Proc; 2010 Jun; 42(5):1808-11. PubMed ID: 20620528
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; O'Brien RJ; Struck J; Quinn P; Morgenthaler N; Squire I; Davies J; Bergmann A; Ng LL
J Am Coll Cardiol; 2007 Apr; 49(14):1525-32. PubMed ID: 17418290
[TBL] [Abstract][Full Text] [Related]
8. Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure.
Stoiser B; Mörtl D; Hülsmann M; Berger R; Struck J; Morgenthaler NG; Bergmann A; Pacher R
Eur J Clin Invest; 2006 Nov; 36(11):771-8. PubMed ID: 17032344
[TBL] [Abstract][Full Text] [Related]
9. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
[TBL] [Abstract][Full Text] [Related]
10. Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients.
Meijer E; Bakker SJ; de Jong PE; Homan van der Heide JJ; van Son WJ; Struck J; Lems SP; Gansevoort RT
Transplantation; 2009 Aug; 88(4):561-7. PubMed ID: 19696640
[TBL] [Abstract][Full Text] [Related]
11. Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock.
Morgenthaler NG; Müller B; Struck J; Bergmann A; Redl H; Christ-Crain M
Shock; 2007 Aug; 28(2):219-26. PubMed ID: 17515850
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
13. Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study.
Maisel A; Xue Y; Shah K; Mueller C; Nowak R; Peacock WF; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand IS; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
Circ Heart Fail; 2011 Sep; 4(5):613-20. PubMed ID: 21765124
[TBL] [Abstract][Full Text] [Related]
14. Copeptin as a biomarker in heart failure.
Balling L; Gustafsson F
Biomark Med; 2014; 8(6):841-54. PubMed ID: 25224940
[TBL] [Abstract][Full Text] [Related]
15. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level.
Katan M; Morgenthaler N; Widmer I; Puder JJ; König C; Müller B; Christ-Crain M
Neuro Endocrinol Lett; 2008 Jun; 29(3):341-6. PubMed ID: 18580851
[TBL] [Abstract][Full Text] [Related]
16. Incremental value of copeptin for rapid rule out of acute myocardial infarction.
Reichlin T; Hochholzer W; Stelzig C; Laule K; Freidank H; Morgenthaler NG; Bergmann A; Potocki M; Noveanu M; Breidthardt T; Christ A; Boldanova T; Merki R; Schaub N; Bingisser R; Christ M; Mueller C
J Am Coll Cardiol; 2009 Jun; 54(1):60-8. PubMed ID: 19555842
[TBL] [Abstract][Full Text] [Related]
17. Copeptin in relation to New York Heart Association class in heart transplant recipients and kidney transplant recipients.
Malyszko J; Przybylowski P; Koc-Zorawska E; Iaina-Levin N; Sadowski J; Mysliwiec M; Malyszko JS
Transplant Proc; 2010 Dec; 42(10):4259-62. PubMed ID: 21168678
[TBL] [Abstract][Full Text] [Related]
18. Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study).
Das SR; Abdullah SM; Leonard D; Drazner MH; Khera A; McGuire DK; de Lemos JA
Am J Cardiol; 2008 Nov; 102(10):1394-8. PubMed ID: 18993162
[TBL] [Abstract][Full Text] [Related]
19. Role of N-terminal pro-brain natriuretic peptide and cystatin C to estimate renal function in patients with and without heart failure.
Linzbach S; Samigullin A; Yilmaz S; Tsioga M; Zeiher AM; Spyridopoulos I
Am J Cardiol; 2009 Apr; 103(8):1128-33. PubMed ID: 19361601
[TBL] [Abstract][Full Text] [Related]
20. Following brain trauma, copeptin, a stable peptide derived from the AVP precusor, does not reflect osmoregulation but correlates with injury severity.
Kleindienst A; Brabant G; Morgenthaler NG; Dixit KC; Parsch H; Buchfelder M
Acta Neurochir Suppl; 2010; 106():221-4. PubMed ID: 19812953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
